Eva Nouvellon
Overview
Explore the profile of Eva Nouvellon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bouvier S, Fortier M, Nouvellon E, Olivan A, Chea M, Gris J
J Thromb Thrombolysis
. 2024 May;
57(6):1051-1055.
PMID: 38762712
Background: Antiphospholipid antibody syndrome (APS) is an acquired autoimmune disorder characterized by recurrent venous or arterial thrombosis and/or pregnancy complications. Recently, thrombotic APS was linked to increased neutrophil extracellular traps...
2.
Chea M, Bourguignon C, Bouvier S, Nouvellon E, Laurent J, Perez-Martin A, et al.
Eur J Intern Med
. 2023 Dec;
122:47-53.
PMID: 38135584
Background: Intimate partner violence (IPV) targeting women is probably underestimated during a woman's lifetime. Venous thromboembolism (VTE) is a multifactorial disease associated with haemostasis-activating conditions. Minor injuries can trigger VTE....
3.
Guillotin F, Fortier M, Portes M, Demattei C, Mousty E, Nouvellon E, et al.
Front Cell Dev Biol
. 2023 Jan;
10:1099038.
PMID: 36684420
NETosis occurs in the context of infection or inflammation and results in the expulsion of decondensed DNA filaments called NETs (Neutrophil Extracellular Traps) into the extracellular environment. NETosis activates coagulation...
4.
Guillotin F, Fortier M, Portes M, Demattei C, Cultrera L, Loyens M, et al.
Thromb Res
. 2022 Dec;
221:65-68.
PMID: 36473363
No abstract available.
5.
Gris J, Bourguignon C, Bouvier S, Nouvellon E, Laurent J, Perez-Martin A, et al.
Thromb Res
. 2022 Sep;
219:102-108.
PMID: 36152459
Introduction: Limitations in the data used to define thromboprophylaxis for patients with antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial provoked venous thromboembolic event (VTE). We aimed to...
6.
Gris J, Guillotin F, Chea M, Bourguignon C, Nouvellon E, Bouvier S
Semin Thromb Hemost
. 2022 Sep;
49(4):337-347.
PMID: 36108650
Antiphospholipid antibodies (aPL Abs) have long been associated with the occurrence of certain specific pregnancy morbidities, affecting both mother and fetus. Antithrombotic-based prophylactic regimens are the standard of care. Their...
7.
Gris J, Bourguignon C, Bouvier S, Nouvellon E, Laurent J, Perez-Martin A, et al.
Thromb Haemost
. 2022 Apr;
122(10):1779-1793.
PMID: 35472708
Background: Few data are available on thrombotic outcomes during pregnancy and puerperium occurring after an initial provoked venous thromboembolic (VTE) event. Objectives: To describe thrombotic outcomes during pregnancy after a...
8.
Bouvier S, Fortier M, Vincent L, Demattei C, Mousty E, Herzog M, et al.
Thromb Haemost
. 2021 Jan;
121(7):877-890.
PMID: 33423243
NETosis is an innate immune response occurring after infection or inflammation: activated neutrophils expel decondensed DNA in complex with histones into the extracellular environment in a controlled manner. It activates...
9.
Bouvier S, Mousty E, Fortier M, Demattei C, Mercier E, Nouvellon E, et al.
J Thromb Haemost
. 2020 Sep;
18(12):3371-3380.
PMID: 32979032
Background: Placenta-mediated pregnancy complications generate short- and long-term adverse medical outcomes for both the mother and the fetus. Nucleosomes and free DNA (fDNA) have been described in patients suffering from...
10.
Gris J, Bouvier S, Nouvellon E, Lissalde-Lavigne G, Mercier E, Balducchi J, et al.
Thromb Res
. 2017 Mar;
151 Suppl 1:S34-S37.
PMID: 28262231
Antiphospholipid antibodies (APLAbs) are generally considered as risk factors for foetal death, for premature birth ≤34weeks due to severe pre-eclampsia or severe placental insufficiency and for recurrent consecutive spontaneous abortions...